19046-Ovarian Cancer-NA-1530

Ovarian Cancer

3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)

  • Details

ClinicalTrials.gov ID: NCT03955471
Diagnosis Type: NA
USOR Number: 19046

  • Address

7695 South Research Dr
Tempe, AZ 85284
P: (888) 972-2873

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.